Drug details
Xembify (immune globulin subcutaneous, human – klhw injection)
type of Immune Globulins
Xembify (immune globulin subcutaneous, human–klhw) is a 20% immune globulin
solution for subcutaneous injection indicated for treatment of Primary Humoral
Immunodeficiency (PI) in patients 2 years of age and older.
This drug may have the following side effects:
- shortness of breath,
- chest pain,
- dizziness,
- weakness,
- fever,
- swelling,
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- wheezing,
- confusion,
- rapid weight gain,
- rapid heart rate,
- eye pain,
- dark colored urine,
- blue colored lips, fingers, or toes,
- numbness or weakness on one side of the body, and
- chest tightness,
- pale or yellowed skin,
- little or no urination,
- fever with a severe headache,
- neck stiffness,
- increased sensitivity to light,
- chest pain with deep breathing,
- swelling and warmth or discoloration in an arm or a leg
The following drugs are related to Xembify, either as a replacement or used together:
- Asceniv (immune globulin intravenous, human - slra for injection)
- Baygam (immune globulin)
- Bivigam (immune globulin intravenous (human), 10%)
- Carimune (immune globulin intravenous (human) nanofiltered lyophilized preparation)
- Cutaquig (immune globulin intravenous, human)
- Flebogamma (immune globulin (human) intravenous solution)
- Gamunex (immune globulin intravenous (human) 10%)
- Gamunex-C (immune globulin injection (human) 10% caprylate/chromatography purified])
- Hizentra (immune globulin subcutaneous (human) injection)
- HyperRAB (rabies immune globulin [human]) for intramuscular administration)
- HyperRHO Full Dose (rho(d) immune globulin (human) for injection)
- HyperRHO Mini-Dose (rho(d) immune globulin (human) intramuscular administration)
- Panzyga (immune globulin intravenous, human - ifas liquid preparation)